معرفی
David Lissauer is a Professor of Global Maternal and Fetal Health at the University of Liverpool, affiliated with the Department of Women's and Children's Health. He served as deputy director of the Malawi-Liverpool-Wellcome Trust Research Institute and co-leads the NIHR 'SAFE Motherhood' Global Health Research Group. His work focuses on maternal infections, immunity, and global maternal health, particularly in low-income countries.
Research Interests
Lissauer's research addresses maternal infections, sepsis prevention, and recurrent miscarriage. His work emphasizes clinical trials, evidence synthesis, and implementation research to improve maternal healthcare in low-resource settings. Key projects include the AIMS trial and studies on maternal sepsis in Malawi, Uganda, and Pakistan.
Scientific Awards
- NIHR Research Professorship (2020)
Grants
- NIHR Global Health Research Group on Improving Quality of Maternal Healthcare in Africa (2021-2026)
- UK Department of Health & Social Care: PROTECT Trial (2022-2026)
- UK Research and Innovation: Maternal Sepsis Management (2024-2027)
- UK Health Security Agency: NeoVT-AMR (2024)
- Silicon Valley Community Foundation: Maternal Sepsis Reduction (2021-2025)
- WHO Collaboration: APT-Sepsis (2021-2026)
- Medical Research Council: Trained Immunity in BCG Vaccinated Children (2020-2022)
Leadership Roles
Lissauer led the Maternal Health Research Group at the Malawi-Liverpool-Wellcome Trust Research Institute and currently serves as site lead for Women's Health at the University of Liverpool. He collaborates with the Royal College of Obstetricians and Gynaecologists on maternal sepsis guidelines.
